Drug Pricing Activity At US FDA May Be Unique To Gottlieb Tenure

 
• By Derrick Gingery

Steven Grossman argues that the former commissioner possessed the credentials to be out front on the pricing issue, unlike other recent FDA commissioners and the current holder of the office.

US dollars and pills
The US FDA likely is not the primary agency for drug pricing work, a long-time stakeholder argued. • Source: Shutterstock

More from US FDA

More from Agency Leadership